Evidence map›Paper›PMID 31182990›Full record

ArticleOxidative medicine and cellular longevity2019

Upregulation of UCP2 Expression Protects against LPS-Induced Oxidative Stress and Apoptosis in Cardiomyocytes.

Jinda Huang, Wanwan Peng, Yijun Zheng, Hu Hao, Sitao Li, Yu Yao, Yue Ding, Junliang Zhang, Juanjuan Lyu, Qiyi Zeng

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. FOXO1 regulates NLRP3 inflammasome proteins in LPS-induced cardiotoxicity.American journal of translational research · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jinda HuangDepartment of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Wanwan PengDepartment of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Yijun ZhengDepartment of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Hu HaoDepartment of Pediatrics, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China.
Sitao LiDepartment of Pediatrics, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China.
Yu YaoDepartment of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Yue DingDepartment of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Junliang ZhangDepartment of Neonatology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Juanjuan LyuDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0002-8855-0669
Qiyi ZengDepartment of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.ORCID 0000-0003-1475-7111
Zhujiang Hospital · CNSun Yat-sen University · CNNanfang Hospital · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uncoupling protein 2 (UCP2) has a cardioprotective role under septic conditions, but the underlying mechanism remains unclear. This study aimed at investigating the effects of UCP2 on the oxidative stress and apoptosis of cardiomyocytes induced by lipopolysaccharide (LPS). First, LPS increased UCP2 expression in cardiomyocytes in a time-dependent manner. LPS increased the production of lactate dehydrogenase (LDH), reactive oxygen species (ROS), and malondialdehyde (MDA) and decreased the level of superoxide dismutase (SOD). However, UCP2 knockdown increased the LPS-induced cardiac injury and oxidative stress. In addition, LPS damaged the mitochondrial ultrastructure and led to the disruption of mitochondrial membrane potential (MMP), as well as the release of mitochondrial cytochrome c. UCP2 knockdown aggravated mitochondrial injury and the release of mitochondrial cytochrome c. LPS increased the protein levels of Bax and cleaved-caspase-3, decreased the protein level of Bcl-2, and upregulated the protein level of mitogen-activated protein kinase. However, upon UCP2 knockdown, the protein levels of Bax and cleaved-caspase-3 increased even further, and the protein level of Bcl-2 was further decreased. The protein level of phosphorylated p38 was also further enhanced. Thus, UCP2 protects against LPS-induced oxidative stress and apoptosis in cardiomyocytes.

Indexed as

AnimalsApoptosisBlotting, WesternCaspase 3Cells, CulturedLipopolysaccharidesL-Lactate DehydrogenaseMalondialdehydeMembrane Potential, MitochondrialMicroscopy, Electron, TransmissionMyocytes, CardiacOxidative StressRatsReactive Oxygen SpeciesSignal TransductionSuperoxide DismutaseCaspase 3LipopolysaccharidesL-Lactate DehydrogenaseMalondialdehydeReactive Oxygen SpeciesSuperoxide DismutaseUncoupling Protein 2

Identifiers

PMID31182990
PMCPMC6512061
OpenAlexW2942046174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.